Medication treatment for multiple sclerosis in Turkey typically costs from $2,500 to $4,000 depending on the drug protocol, infusion requirements, and specialized diagnostic needs. Patients save around 82% compared to the US, where similar MS therapies average $18,500. Standard Turkish care often includes initial specialist consultations and basic disease-modifying therapy protocols in hubs like Istanbul and Ankara.
- Ocrevus (ocrelizumab): $10,000 to $15,000 for advanced B-cell targeted infusion therapy.
- Diagnostic packages: Typically range from $1,800 to $3,670 including MRI and CSF studies.
- Specialist consultations: Neurologist fees in major centers generally run between $100 and $300.
- Infusion premiums: Specialized clinical supervision for DMTs typically adds 15-20% to the base medication cost.
Bookimed Expert Insight: Choosing JCI-accredited centers like NP Istanbul Brain Hospital or Memorial Sisli ensures top-tier safety. NP Istanbul offers comprehensive diagnostic packages for approximately $3,000 including specialist consultations. These clinics provide access to professors like Baris Topcular who specialize specifically in demyelinating diseases. Patients benefit from government-regulated drug pricing which keeps costs stable regardless of currency fluctuations.